Envoy Medical price to book ratio COCH

Market value divided by the book value of the company's net assets, since 2021.

Today, Oct 23, 2026: 13.9×
5-year median: 16.6×
Against its 5-year history: 39th; percentile: 0 is its lowest day, 100 its highest
5-year range: 3.8× to 104×
Peer median: 2.6×

Envoy Medical's price to book ratio is 13.9× as of Oct 23, 2026.

That is below its 5-year median of 16.6×, close to the middle of its last 5 years.

Over that time it ranged from 3.8× in Nov 2023 to 104× in Nov 2021.

The median for 7 medical instruments and supplies stocks of a similar size is 2.6×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	13.9×	4.8×	18.7×
2025	n/m a value too high to mean anything
2024	16.0×	4.1×	36.8×
2023	5.7×	3.8×	7.7×
2022	n/m a value too high to mean anything
2021	103×	102×	104×

Against its peers

Companies in Medical - Instruments & Supplies nearest Envoy Medical's size, closest first, today.

Company	Price to book ratio
COCHEnvoy Medical	13.9×
NEPHNephros	3.2×
APTAlpha Pro Tech	0.9×
KEQUKewaunee Scientific	1.3×
PDEXPro DEX	4.2×
UTMDUtah Medical Products	1.9×
INFUInfuSystem	4.7×
EMBCEmbecta	n/m
Peer median	2.6×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Envoy Medical

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.